Pollack, S. (2011). The rationale for using hydroxycarbamide in the treatment of sickle cell disease” (Haematologica 2011;96: 488–491). Reply. Ferrata Storti Foundation.
Chicago-tyylinen lähdeviittausPollack, Simeon. The Rationale for Using Hydroxycarbamide in the Treatment of Sickle Cell Disease” (Haematologica 2011;96: 488–491). Reply. Ferrata Storti Foundation, 2011.
MLA-viitePollack, Simeon. The Rationale for Using Hydroxycarbamide in the Treatment of Sickle Cell Disease” (Haematologica 2011;96: 488–491). Reply. Ferrata Storti Foundation, 2011.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.